Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune and metabolic issues are linked, and treating one may worsen another.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Six genetic conditions are often linked to complete scalp hair loss in children.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.